Biosino Bio-Technology and Science Incorporation (HKG:8247)
Hong Kong
· Delayed Price · Currency is HKD 0.6900
0.00 (0.00%)
At close: Jul 2, 2025, 4:00 PM HKT
HKG:8247 Revenue
In the year 2024, Biosino Bio-Technology and Science Incorporation had annual revenue of 263.07M CNY, down -9.00%. Biosino Bio-Technology and Science Incorporation had revenue of 64.62M in the quarter ending December 31, 2024, a decrease of -17.69%.
Revenue
263.07M CNY
Revenue Growth
-9.00%
P/S Ratio
0.36
Revenue / Employee
527.19K CNY
Employees
499
Market Cap
99.85M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 263.07M | -26.00M | -9.00% |
| Dec 31, 2023 | 289.07M | -84.00M | -22.52% |
| Dec 31, 2022 | 373.07M | 24.85M | 7.14% |
| Dec 31, 2021 | 348.23M | 22.97M | 7.06% |
| Dec 31, 2020 | 325.26M | -72.15M | -18.16% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.49B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| Innovent Biologics | 10.03B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| Akeso | 2.26B |
| Sino Biopharmaceutical | 30.72B |
| CSPC Pharmaceutical Group | 28.99B |